| Literature DB >> 21255340 |
Alva Biran1, Sharon Yagur-Kroll, Rami Pedahzur, Sebastian Buchinger, Georg Reifferscheid, Hadar Ben-Yoav, Yosi Shacham-Diamand, Shimshon Belkin.
Abstract
Ever since the introduction of the Salmonella typhimurium mammalian microsome mutagenicity assay (the 'Ames test') over three decades ago, there has been a constant development of additional genotoxicity assays based upon the use of genetically engineered microorganisms. Such assays rely either on reversion principles similar to those of the Ames test, or on promoter-reporter fusions that generate a quantifiable dose-dependent signal in the presence of potential DNA damaging compounds and the induction of repair mechanisms; the latter group is the subject of the present review. Some of these assays were only briefly described in the scientific literature, whereas others have been developed all the way to commercial products. Out of these, only one, the umu-test, has been fully validated and ISO- and OECD standardized. Here we review the main directions undertaken in the construction and testing of bacterial-based genotoxicity bioassays, including the attempts to incorporate at least a partial metabolic activation capacity into the molecular design. We list the genetic modifications introduced into the tester strains, compare the performance of the different assays, and briefly describe the first attempts to incorporate such bacterial reporters into actual genotoxicity testing devices.Entities:
Mesh:
Substances:
Year: 2009 PMID: 21255340 PMCID: PMC3815808 DOI: 10.1111/j.1751-7915.2009.00160.x
Source DB: PubMed Journal: Microb Biotechnol ISSN: 1751-7915 Impact factor: 5.813
Figure 1Correlations between the activation of the sulA promoter fused to different reporter systems, comparing colorimetric (sulA′::phoA) detection with either (A) bioluminescent (sulA′::luxCDABE) detection or (B) electrochemical (sulA′::phoA) detection. Response ratio – fold induction over the non‐induced control.
Published detection thresholds of selected chemicals by genetically engineered bacterial genotoxicity reporters.
| SOS Chromotest | SOS | VITOTOXTM (24), (26), (29) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | ||||||||||
| Reporter gene(s) | ||||||||||
| Host strain | ||||||||||
| Compound | MDC (µM) | |||||||||
| Fungal toxins and antibiotics | ||||||||||
| MMC | 0.01 (12) | 0.016 (19) | 4.3 × 10−3 | 0.046 | 5.3 × 10−3 | 2.9 × 10−4 | 0.93 | 0.012 | 9.1 × 10−3 | 0.011 |
| Doxorubicin | 1.1 (12) | 0.41 (11) | 0.9 | 0.43 | ||||||
| NA | 2.4 (12) | 4.6 | 0.69 | 10.77 | 3.57 | 1.02 | 3.01 | |||
| Bleomycin | 0.04 (12) | 22.5 (11) | 0.35 | |||||||
| Esters | ||||||||||
| MMS | 150 (22) | 63 (19) | 10 | 117 | ||||||
| EMS | 1.8 × 103 (12) | 104 (27) | 2061 | 3414 | ||||||
| DMS | 300 (12) | 6.7 (19) | 7.5 | |||||||
| Nitroso‐, nitro‐ | ||||||||||
| DEN | 5 × 104 (12) | 199 (19) | 2349 | 1.5 × 104 | ||||||
| MNNG | 3.0 (5) | 0.45 (27) | 0.6 | 0.40 | 1 | 0.33 | 1.06 | 0.763 | 0.16 | |
| NPAHs | ||||||||||
| 4‐Nopd | 32 (14) | ND (16) | 10.4 | |||||||
| 3‐NFA | 0.04 (15) | 0.25 (8) | 0.06 | |||||||
| 4‐NQO | 0.1 (12) | 0.02 (19) | 0.042 | 3.16 | 0.018 | 13.1 | ||||
| Furazolidone | 0.22 (17) | < 0.44 (16) | 0.002 | |||||||
| HAs | ||||||||||
| 2‐AA | 1 (22) | 3 (27) | 1.08 | 0.037 | 0.08 | |||||
| 2‐AF | 0.4 (22) | < 274 (27) | 1.1 | |||||||
| PAHs | ||||||||||
| B[a]P | 4 (12) | 2.33 (19) | 3.6 | 0.58 | 5 × 10−5 | |||||
| Fluoranthene | ND (12) | ND (9) | 15.3 | |||||||
| Chrysene | 65 (12) | < 87 (16) | 21.9 | |||||||
| Acridine | ||||||||||
| Acridine orange | 12 (12) | 75 (19) | 0.83 | |||||||
| ICI 191 | 0.5 (12) | 0.7 (27) | 0.68 | 0.3 | ||||||
| 9‐aminoacridine | 46 (12) | ND (16) | 5 | |||||||
| Miscellaneous | ||||||||||
| H2O2 | 1322 (12) | 1000 (27) | 50 | 59 | 84 | 23.5 | 1470 | 286 | 24.7 | 588 |
| CH2O | 623 (12) | > 1000 (27) | 6500 | 305 | 141 | |||||
| Epi | 649 (12) | 3300 (27) | 1383 | |||||||
| EtBr | 127 (12) | 1165 (20) | 0.32 | |||||||
| Metals | ||||||||||
| K2Cr2O7 | 258 (12) | 68 (25) | 0.68 | 14 | ||||||
| CdCl2 | ND (23) | ND (20) | ND | 0.99 | ||||||
MDC, the lowest concentration at which the response is systematically over twice the background; ND, not detected; MMC, mitomycin C; NA, nalidixic acid; MMS, methyl methanesulfonate; EMS, ethyl methanesulfonate; DMS, dimethylsulfate; DEN, diethylnitrosamine; MNNG, N‐methyl‐N′‐nitro‐N‐nitrosoguanidine; 4‐Nopd, 4‐nitro‐o‐phenylenediamine; 3‐NFA, 3‐nitrofluoranthene; 4‐NQO, 4‐nitroquinoline‐N‐oxid; 2‐AA, 2‐aminoanthracene; 2‐AF, 2‐aminoflouren; B[a]P, benzo[a]pyrene; H2O2, hydrogen peroxide; CH2O, formaldehyde; Epi, epichlorohydrin; EtBr, ethidium bromide.
Numbers in parenthesis indicate the following references: 1 –Bartolome ), 2 –Baumstark‐Khan ), 3 –Baumstark‐Khan ), 4 –El Mzibri ), 5 –Hamer ), 6 –Hwang ), 7 –Kostrzynska ), 8 –Mersch‐Sundermann ), 9 –Mersch‐Sundermann ), 10 –Min ), 11 –Muller and Janz (1992), 12 –Nakamura ), 13 –Norman ), 14 –Oda ), 15 –Oda ), 16 –Ohta ), 17 –Pal ), 18 –Ptitsyn ), 19 –Quillardet ), 20 –Quillardet and Hofnung (1985), 21 –Rabbow ), 22 –Reifferscheid ), 23 –Reifferscheid and Heil (1996), 24 –van der Lelie ), 25 –Venier ), 26 –Verschaeve ), 27 –von der Hude ), 28 –Vollmer ) 29 –Westerink ).
Molecular modifications introduced into genotoxicity reporter strains to enhance sensitivity, expand the response spectrum and incorporate metabolic activation capabilities.
| Manipulation | Test | Strain | Modified capabilities | Effect | Reference |
|---|---|---|---|---|---|
|
| SOS Chromotest | PQ37/ | Deficiency in nucleotide excision repair | Increased sensitivity toward certain genotoxicants |
|
| TA1535/ | |||||
| GenoTox | TA1535/ | ||||
| SOS | TA1538/ | ||||
| VITOTOXTM | TA104/ | ||||
| TA1538/ | |||||
| Rec‐lac test | KY946 ϕ( | ||||
| SOS‐Chromotest | PQ243/ | Inactivation of the constitutive 3‐methyl‐adenine DNA glycosylase I | Response to lower concentrations of alkylating agent as MNNG, MMS, etc. | ||
| SOS Chromotest | PQ300/ | Depletes the oxidative stress responses under the control of OxyR transcription regulator | More sensitive to various classes of peroxides and compounds generating peroxides | ||
|
| SOS Chromotest | PQ37/ | Mutation in the core enzymes of lypopolysaccharide (LPS) biosynthesis. Incomplete LPS composed of the ketodeoxyoctanoate‐lipid core. | Higher permeability to substances, especially important with larger hydrophobic genotoxins. |
|
| TA1535/ | |||||
| GenoTox | TA1535/ | ||||
| SOS | TA1538/ | ||||
| VITOTOXTM | TA104/ | ||||
| TA1538/ | |||||
|
| GenoTox | N43/ | Inactivation of the efflux, outer membrane transporter‐TolC | Limited efflux capability, increases sensitivity to genotoxins |
|
| SOS | PB3/ | ||||
| DE112/ | |||||
| KT1008/ | |||||
| NM1011/ | High nitroreductase activity | Highly sensitive towards many nitroarenes as 2‐NF, 1‐NP, etc. | |||
| NM2009/ | Thirteen‐fold higher isoniazid‐ | High sensitivity toward nitro‐ and dinitro‐containing compounds, as wells as arylamins, aminoanzo and HAs. | |||
|
| NM3009/ | High | Increased sensitivity to aromatic amines and nitroarens with/without external MA (S‐9) |
| |
| GenoTox | TGO2/ | ||||
| Human |
| NM6001/ |
| Increased sensitivity to aromatic amines and heterocyclic aromatic amines |
|
| NM6002/ | |||||
| Human CYP1A2 and NADPH–P450 reductase expression in | OY1001/ | 7‐Ethoxyresorufin | Detection of some carcinogenic HAs, without the addition of metabolic activation system (S‐9) | ||
| Human CYP1A2 and NADPH–P450 reductase with | OY1002/ | 7‐Ethoxyresorufin | More sensitive to HAs than the previous strain, with ought external MA. Detects the mutagens APNH and APH. |
CYP1A2, cytochrome P450 1A2; O‐AT, O‐acetyltransferase; NR, nitroreductase; N‐AT, N‐acetyltransferase; HA, hetrocyclic amines; MA, metabolic activation; APNH, aminophenylnorharman; APH, aminophenylharman.
Figure 2Effects on reporter performance of several manipulations of the promoter region of a sulA′::lux construct in E. coli. Data represent the increase in bioluminescence (in relative light units) following a 60 min exposure to different nalidixic acid concentrations. (□) wild‐type; (◆) a mutation near the lexA binding site; () a tandem sulA‐recA promoter; (●) a modification of the −35 consensus sequence; () a promoter‐containing fragment extending into the sulA ORF. Activity is reported as the difference in luminescence intensity (in arbitrary relative light units, RLU) between the induced and non‐induced reactions.
Figure 3A. A silicon‐based micro‐chip comprised of four electrochemical micro‐chambers (2 mm in diameter). B. Close‐up view of a single three‐electrode electrochemical micro‐chamber. C. Layout of the measurement platform comprised of a Perspex seal, micro‐fluidic PDMS moulding, and an electrochemical micro‐chip. D. The assembled micro‐fluidic electrochemical chip system.